Mathews MS, Sharma J, et al: Neurosurgery 2009; 65 (November): 860-865 Endovascular treatment of ischemic stroke within 3 hours of stroke onset in patients in whom IV tissue plasminogen activator is contraindicated or fails is safe, effective, and practical.
Quality of Spine Literature --Has It Improved?
The Quality of Quality of Life Publications in the Spinal Literature: Are We Getting Any Better? The quality of published papers in the spine literature addressing quality-of-life outcomes has improved from 2000 to 2004.
Objective: To determine if the quality of spinal literature dealing with quality-of-life (QOL) outcomes has improved. Design: Systematic retrospective review of the literature. Methods: All abstracts from published manuscripts reporting QOL outcomes in 5 leading spinal journals from 2000-2004 were examined. Each paper was scored according to the criteria of Velanovich and Gill and Feinstein. Changes in the quality of manuscripts over time were assessed. Results: During the study period, 2544 abstracts were identified and reviewed. Of these, 599 were deemed suitable for analysis because they reported QOL outcomes from spinal conditions or interventions. During the study period, the number of articles increased by 36%, and the number of QOL articles increased by 102%. There was a statistically significant improvement in the quality of QOL papers according to the criteria of Velanovich. There was no improvement in quality over the study period using the criteria of Gill and Feinstein. Reviewer's Comments: The authors should be congratulated for performing a systematic review of the literature to address the issue of the quality of clinical studies that report QOL outcomes. They demonstrate, using rigorous criteria, that more papers are using statistical analysis and more papers are using diseasespecific measures. Using 2 different sets of criteria, one demonstrated improvement in quality while the other did not. As with any good study, this one raises far more questions than it answers. The real question is whether better clinical research results in improvement of clinical outcomes. Estimating the impact of clinical literature that addresses QOL outcomes is difficult. Issues surrounding cost, reimbursement, and patient preference are all significant variables in clinical decision-making. Another question important for those interested in comparative outcomes research is whether standardization of clinical outcomes measures is necessary before we can perform meaningful comparisons between studies. These types of issues were not addressed in the current study. The Gill and Feinstein criteria place emphasis on a patient's global rating for their QOL and whether patient-specific factors were incorporated into the final analysis. This approach aims to make the results of QOL studies more meaningful clinically. Establishing minimally important differences for disease-specific measures, as well as health-related QOL measures, will ultimately guide the design of future studies and augment the impact of the results. (Reviewer-Zoher Ghogawala, MD).
